Hyman, Phelps & McNamara, P.C. has once again been ranked as a “Tier 1” law firm in the area of “FDA Law” (both nationally and in Washington, D.C.) by the folks over at U.S. News & World Report, who teamed up with Best Lawyers for the 2015 “Best Law Firms” rankings. More than 12,000 law firms are ranked in 74 practice areas nationally and in as many as 120 practice areas on the metropolitan lists. “[R]ankings are based on a rigorous evaluation process that includes the collection of client and lawyer evaluations, peer review from leading attorneys in their field, and review of additional information provided by law firms as part of the formal submission process,” according to U.S. News. The 2015 list of America’s Best Law Firms can be searched here, or viewed here (we’re noted on page 45).
In addition to the honors from U.S. News & World Report, LMG Life Sciences recently listed HP&M as “Highly Recommended” in the areas of Pharmaceuticals and Medical Devices. Here’s what they had to say about us:
Hyman Phelps & McNamara represents one of — if not the most well-respected regulatory boutique firms catering to clients in the life sciences. Tellingly, when asked for a summary of the preeminent regulatory attorneys active in the industry, one industry peer responded, “Hyman Phelps as a whole comes to mind before any-one else.” Various practitioners with the firm inspired the praise of their peers with Jeff Gibbs, Bob Dormer and Alan Kirschenbaum the most regular recipients of accolades. One industry peer said of Kirschenbaum, “he is absolutely top notch,” while the firm generally was described as “the most rounded FDA practice” with respondents highlighting its work on behalf of food manufacturers and pharmaceutical companies in particular.
In fact, the firm’s ability to handle all matters under the jurisdiction of the FDA, from food to drugs and devices to cosmetics, affords clients access to a substantial knowledge base exemplified through the experience of attorneys with specialized practices in every area related to the FDA as well as complementary agencies like the DEA.
One client summed up the general consensus concerning Hyman Phelps succinctly: “there are many Washington firms that focus entirely on regulatory work, with the best example of that type of dedicated practice being Hyman Phelps.”
Wow! We’re blushing.